LC MS

LC MS Market Outlook

The Global Liquid Chromatography-Mass Spectrometry (LC-MS) market is anticipated to reach approximately USD 10 billion by 2035, growing at a compound annual growth rate (CAGR) of around 8.5% during the forecast period from 2025 to 2035. This robust growth trajectory can be attributed to the increasing demand for precise and accurate analytical techniques across various sectors, especially in pharmaceuticals and biotechnology, where LC-MS is critical for drug development, quality control, and testing. Additionally, the rising prevalence of chronic diseases has propelled the need for advanced diagnostic methods, further amplifying the market demand. The expansion of research activities in proteomics and metabolomics, along with technological advancements in LC-MS systems, is also expected to significantly contribute to market growth. Furthermore, the growing focus on environmental testing and food safety is driving the adoption of LC-MS technology in regulatory frameworks.

Growth Factor of the Market

The LC-MS market is witnessing significant growth due to a multitude of factors that are transforming the landscape of analytical chemistry. One of the primary drivers is the rising need for high-throughput screening processes in drug development, which LC-MS efficiently facilitates through its ability to analyze complex samples rapidly and accurately. Furthermore, the increasing emphasis on personalized medicine and tailored therapeutic strategies is prompting pharmaceutical companies to invest in advanced LC-MS technologies for biomarker discovery and validation. Additionally, the growing awareness regarding food safety and environmental sustainability is compelling regulatory bodies to enforce stringent testing measures, leading to heightened demand for LC-MS in these sectors. Technical advancements, such as miniaturization and the integration of artificial intelligence in LC-MS systems, are also enhancing operational efficiencies and broadening their application scope, thereby stimulating market growth. Lastly, the expansion of research activities in emerging economies is expected to create new opportunities for LC-MS adoption, further fueling the market’s expansion.

Key Highlights of the Market

• The LC-MS market is projected to reach around USD 10 billion by 2035.
• Technological advancements are leading to more efficient and compact LC-MS systems.
• The pharmaceutical and biotechnology sectors are the largest consumers of LC-MS technology.
• Increased regulatory scrutiny is driving demand for LC-MS in environmental and food safety testing.
• Emerging economies are becoming significant contributors to market growth through increased research activities.

By Product Type

Liquid Chromatography-Mass Spectrometry Systems:

Liquid Chromatography-Mass Spectrometry (LC-MS) systems are the backbone of this market, combining the separation capabilities of liquid chromatography with the detection power of mass spectrometry. These systems are widely utilized in various applications such as drug discovery, clinical research, and environmental analysis due to their high sensitivity and specificity. The integration of these technologies allows for the efficient analysis of complex biological matrices, making them invaluable in pharmaceutical research and development. Furthermore, technological advancements have led to the development of more compact and user-friendly LC-MS systems, which are increasingly being adopted in laboratories and research facilities worldwide. As the demand for intricate analysis continues to grow, the LC-MS systems segment is expected to dominate the market, driven by innovations that enhance performance and ease of use.

Liquid Chromatography Systems:

Liquid chromatography systems play a crucial role in the separation phase of the LC-MS process. These systems are designed to efficiently separate chemical mixtures into their individual components before they are analyzed by mass spectrometers. The increasing demand for high-resolution separation techniques in various industries, particularly pharmaceuticals and biotechnology, is propelling the growth of this segment. Technological advancements, such as the incorporation of high-performance liquid chromatography (HPLC) systems, are improving the efficiency and resolution of separations, which is a key requirement in drug development and quality control processes. As laboratories strive for faster and more efficient workflows, the liquid chromatography systems segment is expected to witness substantial growth, fueled by advancements that enhance throughput and accuracy.

Mass Spectrometry Systems:

Mass spectrometry systems are integral to the LC-MS market, providing the analytical capabilities required to identify and quantify chemical compounds. These systems are characterized by their ability to analyze complex mixtures with high sensitivity and specificity, which is essential for applications in clinical diagnostics, environmental testing, and food safety. The evolution of mass spectrometry technology, particularly in the areas of tandem mass spectrometry (MS/MS) and high-resolution mass spectrometry (HRMS), has expanded the range of applications and improved the overall performance of these systems. The growing emphasis on accuracy and reliability in analytical results, coupled with increasing regulatory requirements, is driving the demand for mass spectrometry systems within the LC-MS market. As industries prioritize precise quantitative analysis, this segment is poised for significant growth in the coming years.

Accessories:

Accessories for LC-MS systems, including sample preparation tools, columns, and analytical software, are essential components that enhance the overall efficiency and reliability of the analytical process. The market for accessories is growing in parallel with the increasing adoption of LC-MS technologies across various sectors. Innovations in sample preparation techniques, such as solid-phase extraction and online sample cleanup, are improving the quality of analytical results and contributing to the market's expansion. Additionally, advancements in software solutions that provide data analysis and management capabilities are becoming increasingly important, as they enable researchers to handle the vast amounts of data generated by LC-MS systems effectively. The demand for high-quality accessories that enhance system performance and analytical accuracy is expected to drive growth in this segment, further complementing the overall LC-MS market.

By Application

Pharmaceuticals:

The pharmaceutical sector is one of the largest applications for LC-MS technology, driven by the need for accurate and efficient analysis of drug compounds during various stages of development. LC-MS is extensively used for pharmacokinetic studies, bioanalysis, and quality control, enabling the detection of drug metabolites and impurities with high sensitivity. Furthermore, the shift towards personalized medicine is increasing the demand for LC-MS in biomarker discovery and validation. As pharmaceutical companies strive to expedite drug development processes while ensuring compliance with stringent regulatory standards, the application of LC-MS technology becomes indispensable, resulting in sustained growth in this segment.

Biotechnology:

In the biotechnology sector, LC-MS is pivotal for analyzing biomolecules such as proteins, peptides, and nucleic acids. The ability to analyze complex biological samples and identify specific biomolecular interactions is essential for various applications, including biomarker discovery, proteomics, and metabolomics. The increasing investment in biotechnology research and development, coupled with the growing focus on understanding disease mechanisms, is driving the adoption of LC-MS technologies. Furthermore, as the demand for biopharmaceutical products rises, the need for robust analytical methods to characterize and quantify these products will continue to fuel the growth of the LC-MS market in the biotechnology segment.

Clinical Diagnostics:

LC-MS technology is playing an increasingly vital role in clinical diagnostics due to its high sensitivity and specificity in detecting biomolecules in biological samples. It is widely utilized for therapeutic drug monitoring, toxicology screening, and the detection of disease biomarkers, contributing to improved patient outcomes. The growing prevalence of chronic diseases, alongside the rising demand for early and accurate diagnosis, is propelling the adoption of LC-MS in clinical laboratories. As healthcare providers seek to enhance diagnostic capabilities and streamline workflows, the clinical diagnostics segment is expected to experience robust growth, supported by advancements in LC-MS instrumentation and methodologies.

Environmental Testing:

Environmental testing is another critical application of LC-MS technology, essential for assessing the presence of pollutants and contaminants in air, water, and soil samples. The increasing regulatory pressure to monitor environmental pollutants is driving the demand for advanced analytical techniques like LC-MS, which can detect trace levels of contaminants with high precision. Additionally, the rising awareness of environmental sustainability and the importance of food safety are further stimulating the adoption of LC-MS methods in environmental laboratories. With the growing global focus on sustainable practices and compliance with environmental regulations, the environmental testing segment is poised for substantial growth in the coming years.

Others:

The "Others" category encompasses a range of applications that utilize LC-MS technology, including food safety, agricultural testing, and forensic analysis. The versatility of LC-MS systems allows them to be adapted for various analytical challenges across diverse fields. The growing concern over food safety and the need for accurate testing of food products for contaminants and adulterants are driving demand in this sector. Additionally, forensic laboratories are increasingly employing LC-MS for the analysis of substances in criminal investigations, further expanding the market's application landscape. As awareness of the importance of accurate testing in these areas rises, the "Others" segment is expected to witness significant growth driven by the versatility and reliability of LC-MS technology.

By End User

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies are the primary end users of LC-MS technology, leveraging its capabilities for drug discovery, development, and quality control. The high sensitivity and specificity of LC-MS make it an invaluable tool for pharmacokinetic studies, enabling researchers to monitor drug metabolism and identify potential therapeutic targets. As the push for personalized medicine intensifies, these companies increasingly depend on LC-MS for biomarker discovery and validation, ensuring that targeted therapies are based on precise molecular profiles. Furthermore, the growing complexity of modern drug formulations necessitates advanced analytical techniques like LC-MS, which can provide comprehensive insights into drug interactions and stability, driving sustained demand from this segment.

Research Institutes:

Research institutes across the globe are major end users of LC-MS technology, utilizing it for various scientific studies that require precise analytical methods. These institutions leverage LC-MS in fields such as proteomics, metabolomics, and environmental science, where accurate measurement and identification of complex chemical compounds are critical. The rising trend of interdisciplinary research, coupled with increasing funding for scientific investigations, is propelling the demand for LC-MS systems in research settings. Furthermore, as research institutes strive for innovation and excellence, the adoption of advanced analytical techniques like LC-MS will continue to grow, reinforcing its importance in both academic and commercial laboratories.

Contract Research Organizations:

Contract Research Organizations (CROs) are pivotal in the LC-MS market, providing outsourced research services to pharmaceutical and biotechnology companies. These organizations utilize LC-MS technology to conduct bioanalytical testing, pharmacokinetic studies, and toxicology assessments on behalf of their clients. The increasing trend of outsourcing research activities is driving the demand for LC-MS services, as CROs aim to deliver timely and cost-effective solutions. The ability of LC-MS to analyze complex biological matrices with high accuracy is a significant advantage for CROs, allowing them to meet stringent regulatory requirements while providing valuable data to support drug development processes. As the reliance on CROs continues to grow, so too will the demand for LC-MS capabilities within this sector.

Hospitals & Clinics:

Hospitals and clinics are increasingly adopting LC-MS technology for clinical diagnostics, particularly in the areas of therapeutic drug monitoring and toxicology screening. The high sensitivity and specificity of LC-MS make it an essential tool for detecting low concentrations of drugs and metabolites in biological samples, enabling healthcare providers to make informed decisions regarding patient treatment. With the rising prevalence of chronic diseases and the increasing focus on personalized medicine, the demand for advanced diagnostic methods is expected to grow. Additionally, as healthcare facilities seek to enhance their diagnostic capabilities and improve patient outcomes, LC-MS will play a critical role in shaping the future of clinical diagnostics within hospitals and clinics.

Others:

The "Others" category encompasses various end users that leverage LC-MS technology, including government agencies, environmental testing laboratories, and academic institutions. These organizations utilize LC-MS for diverse applications, such as regulatory compliance testing, food safety analysis, and forensic investigations. The increasing emphasis on environmental monitoring and public safety is driving demand from government agencies for robust analytical methods capable of detecting harmful substances in various matrices. Additionally, academic institutions employ LC-MS for educational and research purposes, further expanding the market's reach. As awareness of the importance of accurate analytical testing continues to grow, the "Others" segment will experience significant growth fueled by the versatility and reliability of LC-MS technology.

By Region

The global LC-MS market is characterized by significant regional variations in adoption and growth. North America holds a substantial share of the market, primarily driven by the presence of major pharmaceutical and biotechnology companies, along with well-established research institutions. The market in North America is expected to reach approximately USD 4 billion by 2035, growing at a CAGR of around 8% from 2025 to 2035. This growth is fueled by the increasing demand for advanced analytical techniques, stringent regulatory requirements, and significant investments in R&D activities. Additionally, the rising prevalence of chronic diseases and the focus on personalized medicine are further driving the adoption of LC-MS technology in this region. Europe follows closely, with a robust market driven by similar factors, including the presence of leading research institutes and a growing emphasis on environmental safety regulations.

In the Asia Pacific region, the LC-MS market is expected to witness rapid growth, with projections indicating a potential market size of around USD 2.5 billion by 2035. The CAGR in this region is anticipated to be approximately 10%, driven by the increasing investments in pharmaceutical R&D and growing awareness about food safety and environmental testing. Countries like China, India, and Japan are becoming critical players in the global LC-MS market as they expand their research capabilities and enhance regulatory compliance in various sectors. Latin America and the Middle East & Africa are also experiencing growth, albeit at a slower pace, as these regions gradually adopt LC-MS technologies in response to growing industrialization and increasing regulatory pressures. The total share of these regions is projected to remain under USD 1.5 billion collectively by 2035, highlighting the contrasting growth trajectories across the globe.

Opportunities

The LC-MS market presents numerous opportunities for growth, particularly in emerging economies where investments in research and development are on the rise. As countries in the Asia Pacific region, such as China and India, continue to expand their pharmaceutical and biotechnology sectors, the demand for advanced analytical techniques like LC-MS is expected to increase significantly. Furthermore, these regions are witnessing a surge in regulatory initiatives aimed at enhancing food safety and environmental monitoring, which will further drive the adoption of LC-MS technologies. This opens up avenues for both established companies and new entrants to invest in the development and distribution of LC-MS systems and related accessories tailored to meet the specific needs of these growing markets. Additionally, the integration of artificial intelligence and machine learning into LC-MS systems presents an opportunity for innovation, allowing for more efficient data analysis and improved decision-making processes in laboratories.

Moreover, the ongoing trend towards personalized medicine is creating further opportunities within the LC-MS market. As healthcare providers seek to develop tailored therapeutic strategies based on individual patient profiles, the demand for advanced biomarker discovery and validation techniques will rise. LC-MS technology plays a crucial role in this process, enabling the identification and quantification of biomarkers with high accuracy. This trend will not only drive demand in the pharmaceutical and biotechnology sectors but will also create opportunities for collaboration between different stakeholders, including academic institutions and private companies, to advance research in personalized medicine. As the market continues to evolve, the potential for innovative applications and technologies will provide ample opportunities for growth and expansion in the LC-MS landscape.

Threats

Despite the robust growth prospects, the LC-MS market faces several threats that could impact its trajectory. One of the primary challenges is the high cost associated with acquiring and maintaining LC-MS systems, which may deter smaller laboratories and research institutes from investing in this advanced technology. The complexity of LC-MS systems also necessitates specialized training and expertise, which can limit accessibility for some organizations. Additionally, there is a constant risk of rapid technological advancements that may render existing systems obsolete, forcing companies to invest continuously in upgrades and new technologies to remain competitive. This environment can create significant financial pressure, particularly for smaller players in the market. Furthermore, the increasing regulatory scrutiny and compliance requirements can pose challenges, as organizations must navigate complex guidelines while ensuring that their analytical methods meet stringent standards.

Moreover, the growing trend of outsourcing research and analytical services to Contract Research Organizations (CROs) may pose a threat to traditional laboratory settings that rely heavily on in-house LC-MS capabilities. As CROs become more prevalent, the competition among laboratories to maintain market share could increase, potentially leading to price wars and reduced profitability. Furthermore, economic downturns and fluctuations in funding for research activities can hinder market growth, as organizations may scale back investments in advanced analytical technologies during uncertain times. As these challenges unfold, stakeholders in the LC-MS market must remain vigilant and adaptable to navigate the evolving landscape while capitalizing on emerging opportunities.

Competitor Outlook

• Agilent Technologies
• Thermo Fisher Scientific
• Waters Corporation
• PerkinElmer
• Bruker Corporation
• AB Sciex
• Shimadzu Corporation
• F.Hoffmann-La Roche Ltd
• Merck KGaA
• Restek Corporation
• Malvern Panalytical
• JASCO
• Bio-Rad Laboratories
• GE Healthcare
• Applied Biosystems

The competitive landscape of the LC-MS market is characterized by the presence of several key players that dominate the industry through innovative product offerings and strategic collaborations. Leading companies such as Agilent Technologies, Thermo Fisher Scientific, and Waters Corporation are at the forefront of technological advancements in LC-MS, consistently introducing cutting-edge systems and solutions to meet the evolving needs of researchers and laboratories. These companies invest heavily in research and development to enhance the performance and capabilities of their LC-MS systems, focusing on improving sensitivity, resolution, and ease of use. Additionally, they often engage in strategic partnerships and collaborations with academic institutions and research organizations to foster innovation and expand their market reach.

Moreover, smaller and emerging players are also finding their niche within the LC-MS market by offering specialized solutions and services that cater to specific applications or industries. Companies like Bruker Corporation and AB Sciex are known for their robust mass spectrometry systems that cater to various sectors, including pharmaceuticals, environmental testing, and clinical diagnostics. These companies often emphasize customer support and tailored solutions to differentiate themselves from larger competitors, allowing them to capture market share in specific segments. The level of competition is expected to intensify as organizations strive to stay ahead of technological advancements and meet the growing demand for advanced analytical solutions across various industries.

As the LC-MS market continues to evolve, players will need to adapt to changing consumer preferences, regulatory requirements, and technological advancements. Companies that focus on innovation, quality, and customer-centric solutions will be better positioned to thrive in this competitive landscape. For instance, the integration of artificial intelligence and automation into LC-MS systems is becoming increasingly significant, enabling more efficient data analysis and enhancing laboratory workflows. Key players that successfully leverage these technologies and address emerging trends, such as personalized medicine and environmental testing, will likely lead the market and gain a competitive edge in the years to come. Continuous investment in research and development, along with a keen understanding of market dynamics, will be critical for sustained success in the LC-MS industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 JASCO
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 AB Sciex
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PerkinElmer
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 GE Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Applied Biosystems
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Bruker Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Restek Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Waters Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Malvern Panalytical
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Shimadzu Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 F.Hoffmann-La Roche Ltd
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 LC MS Market, By End User
    • 6.1.1 Pharmaceutical & Biotechnology Companies
    • 6.1.2 Research Institutes
    • 6.1.3 Contract Research Organizations
    • 6.1.4 Hospitals & Clinics
    • 6.1.5 Others
  • 6.2 LC MS Market, By Application
    • 6.2.1 Pharmaceuticals
    • 6.2.2 Biotechnology
    • 6.2.3 Clinical Diagnostics
    • 6.2.4 Environmental Testing
    • 6.2.5 Others
  • 6.3 LC MS Market, By Product Type
    • 6.3.1 Liquid Chromatography-Mass Spectrometry Systems
    • 6.3.2 Liquid Chromatography Systems
    • 6.3.3 Mass Spectrometry Systems
    • 6.3.4 Accessories

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 LC MS Market by Region
  • 10.2 Europe - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 UK
      • 10.2.1.2 France
      • 10.2.1.3 Germany
      • 10.2.1.4 Spain
      • 10.2.1.5 Italy
  • 10.3 Asia Pacific - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 India
      • 10.3.1.2 China
      • 10.3.1.3 Japan
      • 10.3.1.4 South Korea
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global LC MS market is categorized based on

By Product Type

• Liquid Chromatography-Mass Spectrometry Systems
• Liquid Chromatography Systems
• Mass Spectrometry Systems
• Accessories

By Application

• Pharmaceuticals
• Biotechnology
• Clinical Diagnostics
• Environmental Testing
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Contract Research Organizations
• Hospitals & Clinics
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Agilent Technologies
• Thermo Fisher Scientific
• Waters Corporation
• PerkinElmer
• Bruker Corporation
• AB Sciex
• Shimadzu Corporation
• F.Hoffmann-La Roche Ltd
• Merck KGaA
• Restek Corporation
• Malvern Panalytical
• JASCO
• Bio-Rad Laboratories
• GE Healthcare
• Applied Biosystems